David J. Witter
- Molecular Biology top 10%
- Organic Chemistry top 5%
- Pharmacology top 5%
- Oncology top 10%
- Biotechnology top 5%
- Co-authors
- Thomas A. MillerSandro BelvedereJohn C. VederasJohan P. van den HeeverKarine AuclairAndrew SutherlandJonathan KennedyC. Richard Hutchinson
- Topics
- Histone Deacetylase Inhibitors Research (8 papers)Peptidase Inhibition and Analysis (6 papers)Protein Degradation and Inhibitors (5 papers)
- Partner nations
- United StatesCanada
In The Last Decade
David J. Witter
19 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 74
- Molecular Biology 890
- Organic Chemistry 411
- Pharmacology 272
- Oncology 255
- Biotechnology 109
Countries citing papers authored by David J. Witter
This map shows the geographic impact of David J. Witter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David J. Witter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David J. Witter more than expected).
Fields of papers citing papers by David J. Witter
This network shows the impact of papers produced by David J. Witter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David J. Witter. The network helps show where David J. Witter may publish in the future.
Co-authorship network of co-authors of David J. Witter
This figure shows the co-authorship network connecting the top 25 collaborators of David J. Witter. A scholar is included among the top collaborators of David J. Witter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David J. Witter. David J. Witter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 17 | |
| 2 | 20 | |
| 3 | 20 | |
| 4 | 31 | |
| 5 | 36 | |
| 6 | 30 | |
| 7 | 80 | |
| 8 | 13 | |
| 9 | 26 | |
| 10 | 14 | |
| 11 | 468 | |
| 12 | 190 | |
| 13 | 30 | |
| 14 | 29 | |
| 15 | 49 | |
| 16 | 22 | |
| 17 | 17 | |
| 18 | 36 | |
| 19 | 10 |
About David J. Witter
David J. Witter is a scholar working on Pharmacology, Organic Chemistry and Oncology, having authored 19 papers that have together received 1.1k indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (8 papers), Peptidase Inhibition and Analysis (6 papers) and Protein Degradation and Inhibitors (5 papers). The work is most often cited by research in Pharmacology (272 citations), Organic Chemistry (411 citations) and Molecular Biology (890 citations). David J. Witter has collaborated with scholars based in United States and Canada. Frequent co-authors include Thomas A. Miller, Sandro Belvedere, John C. Vederas, Johan P. van den Heever, Karine Auclair, Andrew Sutherland, Jonathan Kennedy, C. Richard Hutchinson, Kevin J. Wilson and J. Paul Secrist. Their work appears in journals such as Journal of the American Chemical Society, Biochemistry and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.